BofA raised the firm’s price target on Revvity to $127 from $118 and keeps a Neutral rating on the shares, stating that Q2 results, guidance and commentary were “mostly consistent with expectations” and peer reports. The firm’s multiple and FY25 EBITDA were raised to reflect recent performance, but it reiterates a Neutral rating as it awaits a return to more normal market conditions.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RVTY: